InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by DeFrancesco Lisa, 董事. Insider active across 2 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 5 filings have been logged. History available since 1 September 2021. The latest transaction was filed on 31 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to DeFrancesco Lisa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
24,674 股Common StockSEC:0001062822-26-000037:0
24,673 股Common StockSEC:0001127602-25-007527:0
542 股@ US$16.2945.2% 占其流量Common StockSEC:0001104659-22-000929:0
204 股@ US$14.8515.2% 占其流量Common StockSEC:0001104659-21-122561:0
538 股@ US$15.0539.6% 占其流量Common StockSEC:0001104659-21-113041:0
5 条申报中的 5 条
About DeFrancesco Lisa
Lisa DeFrancesco is SVP of Investor Relations and Corporate Affairs at INTERCEPT PHARMACEUTICALS, INC. She oversees communications with investors and contributes to the company's strategy. Her role is essential in ensuring transparency and investor trust.
